Delee Corp (Health Care, Medical Devices) — Funding, Investors & Signals 2026

Delee Corp

Enabling radical solutions for science and medicine

Founded 2017

California, United States 15 employees Equity Crowdfunding Total: $2.37M Health Care, Medical Devices +1

Delee is a medical device company founded in 2016, with a focus on revolutionizing early cancer diagnosis and management. Their flagship product, CytoCatch™, boasts a patent-pending technology catered to a CTC blood-based assay, aiming to facilitate the early detection of cancer and monitor the efficacy of treatments. The core of this ground-breaking technology lies in its isolation platform, which streamlines sample processing and captures CTCs, complemented by an integrated imaging system empowered with specialized routines and machine learning algorithms to analyze the captured cells based on their morphology and specific marker expression. Notably, the automation of these processes not only bolsters the reliability and reproducibility of the assay by minimizing errors and cell loss but also makes the collected cells compatible with conventional molecular biology techniques and next-generation technologies, thus simplifying molecular analysis for evaluating the genetic characteristics of captured CTCs. The recent Equity Crowdfunding investment on 01 October 2022 attracted significant backing from Bay Wharf Capital and Occoquan Capital, signaling a promising trajectory for Delee and its innovative cancer-related clinical applications.

Funding Stage	Amount	Investors	Date
Equity Crowdfunding	••••••	2	01 Oct 2022
Seed Round	••••••	-	11 Dec 2019
Pre Seed Round	••••••	-	12 May 2019
Seed Round	••••••	1	07 Apr 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Equity Crowdfunding

••••••

01 Oct 2022

Seed Round

••••••

11 Dec 2019

Pre Seed Round

••••••

12 May 2019

Seed Round

••••••

07 Apr 2017

FAQ About Delee Corp

Enabling radical solutions for science and medicine

Delee Corp was founded in 2017.

Delee Corp is headquartered in California, United States.

Delee Corp operates in the following industries: Health Care, Medical Devices, Machine Learning.

Delee Corp has approximately 15 employees.

Delee Corp has completed 4 funding rounds, raising a total of $2.37M. The latest funding stage is Equity Crowdfunding.

Top alternatives and competitors to Delee Corp include Vortex Biosciences, Cellsway, IV Diagnostics, CytoTrack, TellBio, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Delee Corp and Vortex Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Delee Corp

General Information

Track Delee Corp

Discover More

About Delee Corp

Funding Rounds & Investors (4)

Delee Corp Alternatives & Competitors

FAQ About Delee Corp

Don't just browse. Track.